Understanding Hyaluronic Acid in Dermal Fillers

Hyaluronic Acid in Dermal Fillers: A Specification-Led Guide

Hyaluronic acid (HA) is a long-chain polysaccharide that occurs naturally in connective tissue. In a cosmetic product it is not used as a loose powder or a serum ingredient: it is processed into a sterile, viscoelastic gel supplied in a pre-filled syringe. Understanding how that gel is made — and which numbers on a data sheet actually describe it — is the fastest way to compare products from different manufacturers without relying on marketing language.

This guide is written for two readers at once. If you are a distributor, clinic buyer or private-label partner, it is a checklist for evaluating a supplier’s technical file. If you are a first-time reader trying to understand what the term means, the first three sections give the vocabulary you need before talking with a qualified professional. Nothing here is medical advice, a treatment recommendation or a claim about clinical outcomes.

1. From raw material to a gel

Native HA in the body is broken down quickly. To make a gel that holds its shape, manufacturers cross-link the HA chains with a cross-linking agent — BDDE (1,4-butanediol diglycidyl ether) is the one most commonly used in this product class. Cross-linking creates a three-dimensional network that slows degradation and gives the gel its elasticity and cohesivity.

Three consequences follow, and all three are what a buyer should ask about:

• Degree of cross-linking influences how firm the gel is and how it behaves under pressure. It is a formulation parameter, not a quality ranking — a softer gel is not an inferior gel, it is a gel intended for a different purpose.
• HA concentration, usually expressed in mg/ml, tells you how much HA is present per unit volume. Two products with the same concentration can behave very differently if their cross-linking and manufacturing process differ.
• Gel texture — often described as monophasic or biphasic, or by particle/gel sizing — affects how the product flows and how it integrates. Ask the manufacturer which terminology they use and what their own test method is, because these labels are not standardised across the industry.

A responsible supplier will also describe the purification steps used to remove residual cross-linking agent, the sterilisation method, and the limits applied in release testing. Those details belong in the technical file, not in an advertisement.

2. Reading a product data sheet

When you compare two filler data sheets, put them side by side and check the same fields. The table below is the minimum set we recommend; if a supplier cannot provide one of these in writing, treat that as a question to resolve before placing an order.

Field	What it tells you	What to check
HA concentration (mg/ml)	Amount of HA per ml	Same unit of measurement across products; a higher number is not automatically better
Cross-linking agent and process	How the gel network is formed	Whether residual-agent limits and test methods are documented
Gel / particle characterisation	How the product is intended to behave	Manufacturer’s own terminology and test method
Fill volume per syringe	1 ml, 2 ml, 10 ml, 20 ml, 50 ml etc.	Packaging unit vs. declared volume; consistency with the outer carton
Presentation	Pre-filled syringe, vial, needle/cannula included	Exact contents of each box
Lidocaine	Whether the formulation contains it	Only if actually present — never assume from a competitor’s catalogue
Sterilisation and shelf life	How sterility is assured and how long an unopened unit is valid	Expiry dating and storage conditions stated in the IFU
Lot traceability	Ability to trace a unit back to a production batch	Lot number on both syringe and carton
Documentation pack	Certificates, IFU, labelling, regulatory files	Which documents exist and which authority issued them

The last row matters more than most buyers expect. Certificates are issued by specific bodies under specific scopes, and their recognition varies by country. Our CE and ISO 13485 documentation is issued by domestic certification bodies and is available on request; we do not represent it as an EU-notified-body certificate or as automatically accepted in every market. Confirm the current regulatory position in your own country before ordering.

3. Why one HA filler cannot cover every use case

A soft gel designed for superficial fine lines and a firm gel designed for deeper structural volume are different materials. That is why the TOP-Q® catalogue is organised as a set of product lines rather than a single SKU. The names below are product families, not indications — permitted uses are defined by the labelling and IFU in each market.

Product family	Where it sits in the range	Specification page
Fine Line	Lightest texture in the HA line	Fine Line
Derm Line	Mid-range HA presentation	Derm Line
Deep Line	Firmer HA presentation	Deep Line
Ultra Deep	Densest gel in the HA line	Ultra Deep
Red Lips	Dedicated lip presentation	Red Lips
Body Filler 10/20 ml	Mid-volume body presentations	10 ml / 20 ml
Body Filler 50 ml	Largest-volume presentation	50 ml

If you are building a first order, a practical way to think about it is coverage rather than “the best” product: which presentations your market actually asks for, in which volumes, and with which documentation. Start from the full product range and request the specification sheet for each line you intend to carry.

4. Other material classes in the same catalogue

HA is not the only gel type used in aesthetic products, and a portfolio often includes several classes. Three that appear in our range:

• PLLA (poly-L-lactic acid) — a collagen-stimulator class supplied as a 5 ml presentation. See PLLA 5 ml.
• CaHA (calcium hydroxylapatite) — a different particulate system, supplied here as a 1 ml presentation. See CaHA 1 ml.
• PN / polynucleotide boosters — a skin-booster category with its own formulation logic. See PN Booster.

These are distinct material classes with distinct data sheets. Comparing them on HA concentration alone is meaningless, and any comparison of behaviour, duration or outcome would require properly sourced clinical documentation — which is outside the scope of a product page.

5. Questions worth putting to any supplier

Whether you are sourcing for a clinic, a distribution network or a private-label programme, these are the questions that separate a documented manufacturer from a trading catalogue:

1. Which entity actually manufactures the product, and where is the production site?
2. Can you provide the full specification sheet, IFU and labelling artwork for the exact lot you will ship?
3. Which certification body issued each certificate, and what is its scope?
4. How are lot numbers and expiry dates applied to both primary and secondary packaging?
5. What are the stated storage and transport conditions, and who is responsible for maintaining them?
6. What is included in one carton, and what is the minimum order unit?
7. For private-label projects, which elements of packaging and documentation can be adapted, and which are fixed by regulation?

You can send that list directly to our team via the contact page and request the current documentation pack. We supply product specifications and supply information; we do not provide treatment protocols, clinical outcome claims or medical advice. If you want the manufacturing background as well, the About TOP-Q® page describes the company and its product scope.

Frequently asked questions

Is a higher HA concentration automatically a better product? No. Concentration is one formulation parameter among several. Cross-linking, gel texture and the intended presentation all affect how a product behaves, and none of them is a simple quality score.

Are the product-line names an indication of where a product should be used? No. They are catalogue names for different presentations. Permitted use is defined by the approved labelling and IFU in your market, not by a product name on a website.

Do you publish duration or clinical-result figures? We do not make efficacy, duration or clinical-outcome claims on our product pages. Where such information is required for a regulatory submission, it must come from the approved documentation for the specific product and market.

Can I get the certificates before ordering? Yes — request the current documentation pack. Certificates are issued by domestic certification bodies and their acceptance varies by country, so have your own regulatory adviser review them.

Does the site sell products directly? No. TOP-Q® operates as an inquiry-based site for wholesale and professional enquiries; there is no online checkout or retail pricing on this site.

---

This article provides general product and specification information only. It is intended for licensed professionals, authorised distributors and informed readers, and is not medical advice, a treatment recommendation or a substitute for the Instructions for Use. Product availability, permitted use and regulatory status vary by country. Refer to the current IFU and local regulations before making any product decision.